Sana Biotechnology, Inc.’s SANA share price has surged by 7.80%, which has investors questioning if this is right time to sell.

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Fintel reports that on April 23, 2025, Chardan Capital initiated coverage of Tourmaline Bio (NasdaqGS:TRML) with a Buy ...

Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are ...

The EXTRAClean Exosomal RNA Isolation Kit produces high-quality RNA that improves results from small RNA sequencing and ...

Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Nucleus Security, the leader in unified vulnerability and exposure management, today announced it has expanded its executive team with the appointment of Kunal Desai as senior vice president of ...